Skip to content

Author

Parthiban Gunasingham

We have 1 of 2 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Computational Investigation of HDLP Inhibitors toward Anticancer Drug Design: Molecular Dynamics-Based Binding Energy Evaluation and Binding Pocket Characterization

Findings identify SAHA, CHR3996, ACY1215, HAD5, and HAD3 as promising HDAC inhibitor candidates for further lead optimization, experimental validation, and preclinical anticancer drug development.

Parthiban Gunasingham, Dushanan Ramachandran, D. Dissanayake et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.